ReviewExpert review of anticancer therapy2018

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.

Assunta Sgambato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.